-
1
-
-
0001084356
-
Short-term prognosis following acute cerebral ischaemia
-
Kennedy J, Hill MD, Eliasziw M, Buchan AM, Barnett HJ. Short-term prognosis following acute cerebral ischaemia. Stroke 2002; 33: 382.
-
(2002)
Stroke
, vol.33
, pp. 382
-
-
Kennedy, J.1
Hill, M.D.2
Eliasziw, M.3
Buchan, A.M.4
Barnett, H.J.5
-
2
-
-
0141819134
-
Are patients with acutely recovered cerebral ischemia more unstable?
-
Johnston SC, Easton JD. Are patients with acutely recovered cerebral ischemia more unstable? Stroke 2003; 34: 2446-2450.
-
(2003)
Stroke
, vol.34
, pp. 2446-2450
-
-
Johnston, S.C.1
Easton, J.D.2
-
3
-
-
0141646634
-
Early recovery after cerebral ischemia risk of subsequent neurological deterioration
-
Johnston SC, Leira CE, Hansen DM, Adams HP Jr. Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Annals of Neurology 2003; 54: 439-444.
-
(2003)
Annals of Neurology
, vol.54
, pp. 439-444
-
-
Johnston, S.C.1
Leira, C.E.2
Hansen, D.M.3
Adams Jr., H.P.4
-
4
-
-
0024328055
-
Measurements of acute cerebral infarction: A clinical examination scale
-
Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-870.
-
(1989)
Stroke
, vol.20
, pp. 864-870
-
-
Brott, T.1
Adams Jr, H.P.2
Olinger, C.P.3
Marler, J.R.4
Barsan, W.G.5
Biller, J.6
-
5
-
-
0020030008
-
Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974
-
Wiebers DO, Whisnant JP, O'Fallon WM. Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974. Neurology 1982; 32: 459-465.
-
(1982)
Neurology
, vol.32
, pp. 459-465
-
-
Wiebers, D.O.1
Whisnant, J.P.2
O'Fallon, W.M.3
-
6
-
-
4344671170
-
Post-stroke neurological improvement within 7 days is associated with subsequent deterioration due to stroke-related events
-
for the GAIN International Steering Committee and Investigators
-
Aslanyan S, Weir CJ, Lees KR, Johnston CS, for the GAIN International Steering Committee and Investigators. Post-stroke neurological improvement within 7 days is associated with subsequent deterioration due to stroke-related events. Stroke 2004; 35: 2165-2170.
-
(2004)
Stroke
, vol.35
, pp. 2165-2170
-
-
Aslanyan, S.1
Weir, C.J.2
Lees, K.R.3
Johnston, C.S.4
-
7
-
-
0242694372
-
Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): An adaptive dose-response study of UK-279,276 in acute ischemic stroke
-
Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM, Ford GA, et al. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 2003; 34: 2543-2548.
-
(2003)
Stroke
, vol.34
, pp. 2543-2548
-
-
Krams, M.1
Lees, K.R.2
Hacke, W.3
Grieve, A.P.4
Orgogozo, J.M.5
Ford, G.A.6
-
8
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke
-
The National Institute of Neurological Disorders and Stroke, NINDS rt-PA Stroke Study Group, generic
-
The National Institute of Neurological Disorders and Stroke, NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The New England Journal of Medicine 1995; 333: 1581-1587; ref type: generic.
-
(1995)
The New England Journal of Medicine
, vol.333
, pp. 1581-1587
-
-
-
9
-
-
2642713359
-
Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial
-
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment TOAST
-
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998; 279: 1265-1272.
-
(1998)
JAMA
, vol.279
, pp. 1265-1272
-
-
-
10
-
-
0034600485
-
Glycine antagonist (gaveststinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial
-
Lees KR, Asplund K, Carolei A, Davis SM, Diener H-C, Kaste M, et al. Glycine antagonist (gaveststinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. Lancet 2000; 355: 1949-1954.
-
(2000)
Lancet
, vol.355
, pp. 1949-1954
-
-
Lees, K.R.1
Asplund, K.2
Carolei, A.3
Davis, S.M.4
Diener, H.-C.5
Kaste, M.6
-
11
-
-
0034645547
-
Short-term prognosis after emergency department diagnosis of TIA
-
Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284: 2901-2906.
-
(2000)
JAMA
, vol.284
, pp. 2901-2906
-
-
Johnston, S.C.1
Gress, D.R.2
Browner, W.S.3
Sidney, S.4
-
12
-
-
0034706407
-
New transient ischemic attack and stroke: Outpatient management by primary care physicians
-
Goldstein LB, Bian J, Samsa GP, Bonito AJ, Lux LJ, Matchar DB. New transient ischemic attack and stroke: outpatient management by primary care physicians. Archives of Internal Medicine 2000; 160: 2941-2946.
-
(2000)
Archives of Internal Medicine
, vol.160
, pp. 2941-2946
-
-
Goldstein, L.B.1
Bian, J.2
Samsa, G.P.3
Bonito, A.J.4
Lux, L.J.5
Matchar, D.B.6
-
13
-
-
33846124807
-
-
Kennedy J, Eliasziw M, Buchan A, FASTER Group. The Fast Assessment of Stroke and Transient Ischemic Attack (TIA) to Prevent Early Recurrence (FASTER) Trial - Pilot Phase. New Orleans, LA: The American Stroke Association International Stroke Conference, 2-4 February, 2005.
-
Kennedy J, Eliasziw M, Buchan A, FASTER Group. The Fast Assessment of Stroke and Transient Ischemic Attack (TIA) to Prevent Early Recurrence (FASTER) Trial - Pilot Phase. New Orleans, LA: The American Stroke Association International Stroke Conference, 2-4 February, 2005.
-
-
-
-
14
-
-
33846132135
-
-
Sacco RL, Diener HC, Yusuf S, PRoFESS Steering Commitee and Study Group. Prevention Regimen For Effectively avoiding Second Strokes (PRoFESS). New Orleans, LA: The American Stroke Association International Stroke Conference, 2-4 February, 2005.
-
Sacco RL, Diener HC, Yusuf S, PRoFESS Steering Commitee and Study Group. Prevention Regimen For Effectively avoiding Second Strokes (PRoFESS). New Orleans, LA: The American Stroke Association International Stroke Conference, 2-4 February, 2005.
-
-
-
|